Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Binder

Showing results (341-350 of 399) with videos related to

Pageof 40
Sort By:
CNS Oncology|November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastomaIgor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulationDieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
Vaccines|November 25, 2023
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of ProtectionKimia Sobhani, Susan Cheng, Raquel A Binder, et al.
Plos One|March 31, 2016
Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell LinesZev A Binder, Kelli M Wilson, Vafi Salmasi, et al.
Cell Stem Cell|December 10, 2024
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapyMeghan Logun, Xin Wang, Yusha Sun, et al.
European Urology|February 25, 2022
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 TrialSumanta K Pal, Javier Puente, Daniel Y C Heng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastomaNannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Stem Cell Reports|June 20, 2025
Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture modelYusha Sun, Xin Wang, Zhijian Zhang, et al.
Plos One|October 23, 2013
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcomeZev A Binder, I-Mei Siu, Charles G Eberhart, et al.
Pageof 40

Showing results (341-350 of 399) with videos related to

Sort By:
Pageof 40
CNS Oncology|November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastomaIgor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Neuro-Oncology Advances|February 22, 2021
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastomaStephen J Bagley, Jacob Till, Aseel Abdalla, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulationDieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
Vaccines|November 25, 2023
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of ProtectionKimia Sobhani, Susan Cheng, Raquel A Binder, et al.
Plos One|March 31, 2016
Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell LinesZev A Binder, Kelli M Wilson, Vafi Salmasi, et al.
Cell Stem Cell|December 10, 2024
Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapyMeghan Logun, Xin Wang, Yusha Sun, et al.
European Urology|February 25, 2022
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 TrialSumanta K Pal, Javier Puente, Daniel Y C Heng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastomaNannan Li, Jesse L Rodriguez, Yibo Yin, et al.
Stem Cell Reports|June 20, 2025
Cholinergic neuron-to-glioblastoma synapses in a human iPSC-derived co-culture modelYusha Sun, Xin Wang, Zhijian Zhang, et al.
Plos One|October 23, 2013
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcomeZev A Binder, I-Mei Siu, Charles G Eberhart, et al.
Pageof 40